AXTA DOWNLOAD: http://Capital-Review.com/register/?so=AXTA
HD DOWNLOAD: http://Capital-Review.com/register/?so=HD
IMMU DOWNLOAD: http://Capital-Review.com/register/?so=IMMU
KOS DOWNLOAD: http://Capital-Review.com/register/?so=KOS
CASA DOWNLOAD: http://Capital-Review.com/register/?so=CASA
ORA DOWNLOAD: http://Capital-Review.com/register/?so=ORA

The new research reports from Capital Review, available for free download at the links above, examine Axalta Coating Systems Ltd. (NYSE:AXTA), The Home Depot, Inc. (NYSE:HD), Immunomedics, Inc. (NASDAQ:IMMU), Kosmos Energy Ltd. (NYSE:KOS), Casa Systems, Inc. (NASDAQ:CASA), and Ormat Technologies, Inc. (NYSE:ORA) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed February 27th, 2019. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

For the three months ended September 30th, 2018 vs September 30th, 2017, Axalta Coating reported revenue of $1,146.00MM vs $1,096.30MM (up 4.53%) and analysts estimated basic earnings per share -$0.05 vs $0.23. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Axalta Coating reported revenue of $4,377.00MM vs $4,092.70MM (up 6.95%) and analysts estimated basic earnings per share $0.15 vs $0.16 (down 6.25%). Analysts expect earnings to be released on April 24th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.27. The estimated EPS forecast for the next fiscal year is $1.51 and is expected to report on January 29th, 2020.

For the three months ended October 31st, 2018 vs October 31st, 2017, The Home Depot reported revenue of $26,302.00MM vs $25,026.00MM (up 5.10%) and analysts estimated basic earnings per share $2.53 vs $1.85 (up 36.76%). For the twelve months ended January 31st, 2018 vs January 31st, 2017, The Home Depot reported revenue of $100,904.00MM vs $94,595.00MM (up 6.67%) and analysts estimated basic earnings per share $7.33 vs $6.47 (up 13.29%). Analysts expect earnings to be released on May 21st, 2019. The report will be for the fiscal period ending April 30th, 2019. Based on 15 analysts' forecasts, the consensus EPS forecast for the quarter is $2.27. Reported EPS for the same quarter last year was $2.08. The estimated EPS forecast for the next fiscal year is $11.07 and is expected to report on February 25th, 2020.

For the twelve months ended June 30th, 2018 vs June 30th, 2017, Immunomedics reported revenue of $2.16MM vs $3.09MM (down 30.26%) and analysts estimated basic earnings per share -$1.78 vs -$1.47. Analysts expect earnings to be released on May 8th, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was -$0.14. The estimated EPS forecast for the next fiscal year is -$1.36 and is expected to report on August 22nd, 2019.

For the three months ended September 30th, 2018 vs September 30th, 2017, Kosmos Energy reported revenue of $250.22MM vs $151.24MM (up 65.44%) and basic earnings per share -$0.31 vs -$0.16. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Kosmos Energy reported revenue of $636.84MM vs $385.36MM (up 65.26%) and analysts estimated basic earnings per share -$0.57 vs -$0.74. Analysts expect earnings to be released on May 6th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was -$0.06. The estimated EPS forecast for the next fiscal year is $0.47 and is expected to report on February 24th, 2020.

For the three months ended September 30th, 2018 vs September 30th, 2017, Casa reported revenue of $71.51MM vs $94.26MM (down 24.14%) and analysts estimated basic earnings per share $0.22 vs $0.31 (down 29.03%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Casa reported revenue of $351.58MM vs $316.13MM (up 11.21%) and analysts estimated basic earnings per share $0.34 vs -$1.07. Analysts expect earnings to be released on May 9th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.19. The estimated EPS forecast for the next fiscal year is $0.64 and is expected to report on February 20th, 2020.

For the three months ended September 30th, 2018 vs September 30th, 2017, Ormat Technologies reported revenue of $166.48MM vs $157.19MM (up 5.91%) and analysts estimated basic earnings per share $0.21 vs $0.48 (down 56.25%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Ormat Technologies reported revenue of $692.81MM vs $662.59MM (up 4.56%) and analysts estimated basic earnings per share $2.64 vs $1.79 (up 47.49%). Analysts expect earnings to be released on May 6th, 2019. The report will be for the fiscal period ending March 31st, 2019. The reported EPS for the same quarter last year was $0.48. The estimated EPS forecast for the next fiscal year is $2.71 and is expected to report on February 25th, 2020.

Capital Review is a nationally recognized publisher of financial analysis, research reports, and exclusive market reporting. Institutional investors, registered brokers, professional traders, and personal investment advisers rely on Capital Review to quantify public company valuations, discover opportunity across asset classes, stay informed about market-moving events, and read exclusive analysis of important material developments. With 14 offices worldwide, Capital Review staffs and manages certified and registered financial professionals, including Chartered Financial Analyst® (CFA®) designation holders and FINRA® BrokerCheck® certified individuals with current and valid CRD® number designations, to enable continuous coverage of topics relevant to its regular active reader base.

Capital Review's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Capital Review's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Capital Review have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Capital Review's Compliance department by Phone, at +1 (410) 280-7496, or by E-mail at [email protected].

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Capital Review, Capital Review members, and/or Capital Review affiliates are not responsible for any gains or losses that result from the opinions expressed. Capital Review makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Capital Review has not been compensated for the publication of this press release by any of the above mentioned companies. Capital Review is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.